Skip to menu Skip to content Skip to footer

2004

Journal Article

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

Strippoli, Giovanni F.M., Tong, Allison, Johnson, David W., Schena, Francesco Paolo and Craig, Jonathan C. (2004). Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database of Systematic Reviews, 2017 (4) CD004679, CD004679-1-CD004679-63. doi: 10.1002/14651858.CD004679.pub2

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

2004

Journal Article

Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations

McDonald, Stephen P., Collins, John F., Rumpsfeld, Markus and Johnson, David W. (2004). Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Peritoneal Dialysis International, 24 (4), 340-346.

Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations

2003

Journal Article

Body mass index and renal transplant outcomes (Letters to the Editor)

Johnson, David W., Isbel, Nicole M., Brown, Allison M., Kay, Troy D., Franzen, Kirsten, Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony and Nicol, David L. (2003). Body mass index and renal transplant outcomes (Letters to the Editor). Transplantation, 76 (11), 1651-1651. doi: 10.1097/01.TP.0000084541.52199.6F

Body mass index and renal transplant outcomes (Letters to the Editor)

2003

Journal Article

Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants

Campbell, Scott B., Hothersall, Emma, Preston, John, Brown, Allison M., Hawley, Carmel M., Wall, Darryl, Griffin, Anthony D., Isbel, Nicole M., Nicol, David L. and Johnson, David W. (2003). Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants. Transplantation, 76 (10), 1452-1457. doi: 10.1097/01.TP.0000083895.64198.10

Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants

2003

Journal Article

Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations

Mcdonald, Stephen P., Collins, John F. and Johnson, David W. (2003). Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. Journal of The American Society of Nephrology, 14 (11), 2894-2901. doi: 10.1097/01.ASN.0000091587.55159.5F

Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations

2003

Journal Article

Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients

Johnson, David W., Nicol, David L., Preston, John M., Brown, Allison M., Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony D. and Isbel, Nicole M. (2003). Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients. Transplantation, 76 (3), 619-619. doi: 10.1097/01.TP.0000074314.46438.25

Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients

2003

Journal Article

A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor)

Rumpsfeld, M. and Johnson, D. W. (2003). A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor). Peritoneal Dialysis International, 23 (4), 406-408. doi: 10.1177/089686080302300419

A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor)

2003

Journal Article

Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations

Pat, Betty K., Cuttle, Leila, Watters, Dianne, Yang, Tao, Johnson, David W. and Gobe, Glenda C. (2003). Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations. Nephrology, 8 (4), 196-204. doi: 10.1046/j.1440-1797.2003.00162.x

Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations

2003

Journal Article

Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor)

Campbell, Scott B. and Johnson, David W. (2003). Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor). Transplantation, 75 (11), 1917-1918. doi: 10.1097/01.TP.000065807.68596.16

Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor)

2003

Journal Article

Correlates of subclinical left ventricular dysfunction in ESRD

Fathi, Robert, Isbel, Nicole, Haluska, Brian, Case, Colin, Johnson, David W. and Marwick, Thomas H. (2003). Correlates of subclinical left ventricular dysfunction in ESRD. American Journal of Kidney Diseases, 41 (5), 1016-1025. doi: 10.1016/S0272-6386(03)00199-9

Correlates of subclinical left ventricular dysfunction in ESRD

2003

Journal Article

Clinicians' attitudes to clinical practice guidelines

Johnson, David W. (2003). Clinicians' attitudes to clinical practice guidelines. Medical Journal of Australia, 178 (7), 354-355.

Clinicians' attitudes to clinical practice guidelines

2003

Journal Article

A peritoneal dialysis patient with fatal culture-negative peritonitis

Johnson, David W., Gray, Nick and Snelling, Paul (2003). A peritoneal dialysis patient with fatal culture-negative peritonitis. Nephrology, 8 (1), 49-55. doi: 10.1046/j.1440-1797.2003.00119.x

A peritoneal dialysis patient with fatal culture-negative peritonitis

2003

Journal Article

Recommendations for the use of icodextrin in peritoneal dialysis patients

Johnson, David W., Agar, John, Collins, John, Disney, Alex, Harris, David C. H., Ibels, Lloyd, Irish, Ashley, Saltissi, David and Suranyi, Michael (2003). Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology, 8 (1), 1-7. doi: 10.1046/j.1440-1797.2003.00117.x

Recommendations for the use of icodextrin in peritoneal dialysis patients

2003

Journal Article

In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure

Mahmoudi, Mitra, Willgoss, Desley, Cuttle, Leila, Yang, Tao, Pat, Betty, Winterford, Clay, Endre, Zoltan, Johnson, David W. and Gobe, Glenda C. (2003). In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure. Journal of Pathology, 200 (3), 396-405. doi: 10.1002/path.1368

In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure

2003

Journal Article

Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin

Johnson, David W., Vincent, Kaia, Blizzard, Sophie, Rumpsfeld, Markus and Just, Paul (2003). Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin. Advances in Peritoneal Dialysis, 19, 81-85.

Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin

2003

Journal Article

A single-centre experience of post-renal transplant lymphoproliferative disorder

Herzig, Karen A., Juffs, Helen G., Norris, Debra, Brown, Allison M., Gill, Devinder, Hawley, Carmel M., Cobcroft, Ralph, Petrie, James B., Marlton, Paula, Thomson, Damien, Campbell, Scott B., Nicol, David L. and Johnson, David W. (2003). A single-centre experience of post-renal transplant lymphoproliferative disorder. Transplant International, 16 (7), 529-536. doi: 10.1007/s00147-003-0596-0

A single-centre experience of post-renal transplant lymphoproliferative disorder

2003

Journal Article

Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation

Gill, D., Juffs, H. G., Herzig, K. A., Brown, A. M., Hawley, C. M., Cobcroft, R. G., Petrie, J. J., Marlton, P., Kennedy, G., Thomson, D. B., Campbell, S. B., Nicol, D. L., Norris, D. and Johnson, D. W. (2003). Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation. Transplantation Proceedings, 35 (1), 256-257. doi: 10.1016/S0041-1345(02)03796-X

Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation

2003

Journal Article

Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose

Kay T. D., Playford, H. R. and Johnson D. W. (2003). Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose. Clinical Nephrology, 59 (1), 56-58.

Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose

2003

Journal Article

Predictors of decline of residual renal function in new peritoneal dialysis patients

Johnson, David W., Mudge, David W., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M. and Hollett, Peter (2003). Predictors of decline of residual renal function in new peritoneal dialysis patients. Peritoneal Dialysis International, 23 (3), 276-283.

Predictors of decline of residual renal function in new peritoneal dialysis patients

2002

Journal Article

Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism

Vesey, David A., Cheung, Catherine, Cuttle, Leila, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2002). Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. Journal of Laboratory And Clinical Medicine, 140 (5), 342-350. doi: 10.1067/mlc.2002.128468

Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism